Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the ED90 Capacity of Plumazenyl for the Improvement of Respiratory Deterioration During Anesthesia Management Under Monitoring Using Remimazolam - Prospective Study

NCT06563063 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06563063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the ED90 Capacity of Plumazenyl for the Improvement of Respiratory Deterioration During Anesthesia Management Under Monitoring Using Remimazolam - Prospective Study
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2023
Completion date
December 1, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm